EVOKE PHARMA, INC. Employee-related Liabilities, Current
EVOKE PHARMA, INC. had Employee-related Liabilities, Current of $770.91 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2025-11-13
- 2025-09-30: Employee-related Liabilities, Current $770.91K.
- 2025-06-30: Employee-related Liabilities, Current $607.14K.
- 2025-03-31: Employee-related Liabilities, Current $371.73K.
- 2024-12-31: Employee-related Liabilities, Current $865.65K.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2025-09-30 | $770.91K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $607.14K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $371.73K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $865.65K 10-Q · filed 2025-11-13 |
| 2024-09-30 | $590.63K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $425.80K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $265.88K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.32M 10-K · filed 2025-03-13 |
| 2023-09-30 | $829.67K 10-K/A · filed 2024-05-14 |
| 2023-06-30 | $612.93K 10-K/A · filed 2024-05-14 |
| 2023-03-31 | $400.25K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $591.16K 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $716.99K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $528.66K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $412.20K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $519.32K 10-K · filed 2023-03-21 |
| 2021-09-30 | $810.79K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $621.48K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $428.79K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.02M 10-K · filed 2022-03-08 |
| 2020-09-30 | $715.42K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $860.52K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $685.27K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $843.16K 10-K · filed 2021-03-11 |
| 2019-09-30 | $964.24K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $807.71K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $692.30K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.16M 10-K · filed 2020-03-12 |
| 2018-09-30 | $984.68K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $824.85K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $649.62K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $1.03M 10-K · filed 2019-03-06 |
| 2017-09-30 | $927.84K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $757.49K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $586.77K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $933.45K 10-K · filed 2018-03-07 |
| 2016-09-30 | $513.51K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $499.31K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $482.50K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $760.78K 10-K · filed 2017-03-15 |
| 2015-09-30 | $665.55K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $563.75K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $424.60K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $697.25K 10-K · filed 2016-03-10 |
| 2014-09-30 | $636.10K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $537.45K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $385.50K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $557.40K 10-K · filed 2015-03-04 |
| 2013-09-30 | $390.98K 10-Q · filed 2013-11-13 |
| 2012-12-31 | $417.61K 10-K · filed 2014-03-25 |